Compare Main Street Capital Corporation (MAIN) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Main Street Capital Corporation vs 22nd Century Group Inc — how do they compare? Main Street Capital Corporation trades at $58.45 (market cap $5.52B), while 22nd Century Group Inc trades at $4.38 (market cap $1.52M). The key difference: Main Street Capital Corporation is far larger — about 3631.6× 22nd Century Group Inc's market cap, and Main Street Capital Corporation pays a 5.39% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| MAIN | XXII | |
|---|---|---|
Market Cap | $5.52B | $1.52M |
Sector | Financials | Technology |
52-Week High | $67.54 | $801.00 |
52-Week Low | $49.63 | $3.72 |
Dividend Yield | 5.39% | — |
Enterprise Value | — | -$6.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MAIN trades at $58.48, down slightly by 0.07% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported Q2 2026 EPS of $0.97, beating estimates, though Q1 was a miss. Revenue has grown from $318M in 2022 to $592M in 2025, with net income margins above 80%. Recent news highlights MAIN's dividend reliability amid sector challenges, with multiple dividends declared for 2026.
Outlook remains positive given strong profitability and dividend consistency, but risks include expense pressures and sector volatility. Analysts are mostly neutral with a consensus price target of $56.67, below the current price, suggesting limited near-term upside. The stock's high valuation multiples and overbought technicals warrant caution despite solid fundamentals.
XXII trades at $4.38, up 0.69% with neutral technical signals. The company shows concerning fundamentals with negative profit margins (-65.76% net income margin) and ROE of -130.19%, though valuation ratios appear low (P/S 0.03, P/B 0.07). Recent corporate actions include a 20:1 reverse stock split in June 2026. Analyst sentiment remains positive with 75% buy ratings, while the company expands VLN® product distribution in key markets like California and New York.
The outlook remains speculative given persistent losses despite revenue generation. Investment opportunity lies in successful execution of reduced-nicotine cigarette expansion and FDA regulatory progress. Key risks include continued cash burn, competitive pressures, and dependency on regulatory approvals for growth catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
